Development and Evaluation of a Pharmacogenomics Educational Program for Pharmacists

被引:61
作者
Formea, Christine M. [1 ]
Nicholson, Wayne T. [2 ]
McCullough, Kristen B. [1 ]
Berg, Kevin D. [3 ]
Berg, Melody L. [1 ]
Cunningham, Julie L. [1 ]
Merten, Julianna A. [1 ]
Ou, Narith N. [1 ]
Stollings, Joanna L. [4 ]
机构
[1] Mayo Clin, Dept Pharm Serv, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA
[3] St Lukes Hosp, Dept Pharm, Duluth, MN USA
[4] Vanderbilt Univ, Med Ctr, Dept Pharm, Nashville, TN USA
基金
美国国家卫生研究院;
关键词
pharmacogenomics; continuing education; genetic testing; survey; personalized medicine; RETENTION; THERAPY;
D O I
10.5688/ajpe77110
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Objectives. To evaluate hospital and outpatient pharmacists' pharmacogenomics knowledge before and 2 months after participating in a targeted, case-based pharmacogenomics continuing education program. Design. As part of a continuing education program accredited by the Accreditation Council for Pharmacy Education (ACPE), pharmacists were provided with a fundamental pharmacogenomics education program. Evaluation. An 11-question, multiple-choice, electronic survey instrument was distributed to 272 eligible pharmacists at a single campus of a large, academic healthcare system. Pharmacists improved their pharmacogenomics test scores by 0.7 questions (pretest average 46%; posttest average 53%, p=0.0003). Conclusions. Although pharmacists demonstrated improvement, overall retention of educational goals and objectives was marginal. These results suggest that the complex topic of pharmacogenomics requires a large educational effort in order to increase pharmacists' knowledge and comfort level with this emerging therapeutic opportunity.
引用
收藏
页数:8
相关论文
共 23 条
[1]  
[Anonymous], 2011, DRUGS FDA FDA APPR D
[2]   Pharmacogenomics: implications and considerations for pharmacists [J].
Brock, TP ;
Valgus, JM ;
Smith, SR ;
Summers, KM .
PHARMACOGENOMICS, 2003, 4 (03) :321-330
[3]   Development and implementation of a pharmacist-managed clinical pharmacogenetics service [J].
Crews, Kristine R. ;
Cross, Shane J. ;
McCormick, John N. ;
Baker, Donald K. ;
Molinelli, Alejandro R. ;
Mullins, Richard ;
Relling, Mary V. ;
Hoffman, James M. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (02) :143-150
[4]   Potential roles for pharmacists in pharmacogenetics [J].
El-Ibiary, Shareen Y. ;
Cheng, Christine ;
Alldredge, Brian .
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2008, 48 (02) :E21-E31
[5]   Retention of compounding skills among pharmacy students [J].
Eley, John G. ;
Birnie, Christine .
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2006, 70 (06) :132
[6]  
Ellingrod V.L., 2007, J PHARM PRACT, V20, P277, DOI DOI 10.1177/0897190007304820
[7]   Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects [J].
Evans, WE ;
McLeod, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :538-549
[8]   Pharmacogenomics: The inherited basis for interindividual differences in drug response [J].
Evans, WE ;
Johnson, JA .
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2001, 2 :9-39
[9]   Learning outcomes and behavioral changes with a pharmacy continuing professional education program [J].
Fjortoft, NF .
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2006, 70 (02)
[10]   Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues [J].
Gage, Brian F. ;
Lesko, Lawrence J. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2008, 25 (01) :45-51